Inloggen

Login
 
Wachtwoord vergeten?

Analyst reports 2019

Volgen
 
Klik hier om dit forumtopic te volgen en automatisch op de hoogte gehouden te worden bij nieuwe berichten.
382 Posts, Pagina: « 1 2 3 4 5 6 ... 15 16 17 18 19 20 | Laatste
Aantal posts per pagina:  20 50 100 | Omlaag ↓
asti
2
'avantiavanti schreef op 13 december 2019 16:59:

Vervolg Barclays

(...)

…last but not least, the always popular “short covering”
One thing we’ve written extensively about all year is our sense that there’s a big difference in sentiment across the Atlantic in terms of how investors view GLPG. In the US, particularly amongst specialists, we’ve sensed a more bearish consensus towards GLPG (particularly on the peak sales potential of filgotinib and on the viability of the IPF program) than in Europe. Given that there’s a perceived lack of catalysts until either the SELECTION phase 2 data for filgotinib in ulcerative colitis and/or the filgotinib approval/label (whichever comes first, but both likely around mid-year 2020), we’ve heard feedback that GLPG is a popular name to short (particularly with the takeout risk off the table). Thus, this adds to the confusion of GLPG’s recent outperformance and one of the most common refrains we’ve heard lately is that this could be a result of short covering.

However, the short interest for GLPG has actually increased pretty sharply as a % of the float as of late, indicating to us that it’s more the aforementioned “real” buying driving GLPG shares higher vs. short covering.

(...)'


Herinneren jullie je deze post nog? :)
382 Posts, Pagina: « 1 2 3 4 5 6 ... 15 16 17 18 19 20 | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Plaats een reactie

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord

Direct naar Forum

Galapagos Meer »

Koers 249,500   Verschil +6,80 (+2,80%)
Laag 231,200   Volume 783.260
Hoog 250,500   Gem. Volume 516.191
21 feb 2020 17:39
label premium

Galapagos: Filgotinib naar de VS

Het laatste advies leest u als IEX Premium-lid

Inloggen Ontdek Premium

Gerelateerde Video's

Arend Jan Kamp over hoofdkantoren 7 februari 2017 16:38
Arend Jan Kamp over biotech 2 februari 2017 16:33